Alfred L George Selected Research

NAV1.2 Voltage-Gated Sodium Channel

1/2022

Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfred L George Research Topics

Disease

26	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2002
23	Epilepsy (Aura) 10/2022 - 12/2003
21	Long QT Syndrome 01/2021 - 01/2002
13	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2019 - 12/2003
7	Brain Diseases (Brain Disorder) 01/2022 - 10/2014
7	Seizures (Absence Seizure) 01/2021 - 12/2005
7	Torsades de Pointes (Torsade de Pointes) 04/2014 - 03/2002
5	Neurodevelopmental Disorders 01/2022 - 10/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 03/2008
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 03/2002
5	Migraine Disorders (Migraine) 01/2021 - 07/2008
5	Sudden Death 11/2018 - 03/2008
5	Generalized Epilepsy with Febrile Seizures Plus 11/2010 - 06/2002
4	Brugada Syndrome 05/2022 - 01/2002
4	Channelopathies 01/2021 - 08/2005
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 04/2011
4	Sudden Infant Death (SID) 03/2008 - 01/2007
3	Fetal Death 01/2019 - 04/2013
3	Pain (Aches) 06/2017 - 04/2009
3	Ventricular Tachycardia 04/2017 - 07/2004
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017 - 02/2008
3	Drug-Related Side Effects and Adverse Reactions 01/2016 - 01/2002
3	Atrial Fibrillation 11/2014 - 12/2007
3	Hypertension (High Blood Pressure) 04/2014 - 11/2007
3	Myotonia Congenita (Thomsen Disease) 10/2013 - 12/2002
3	Epileptic Syndromes 10/2006 - 06/2002
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 11/2010
2	Alternating hemiplegia of childhood 01/2020 - 01/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 12/2005
2	Ventricular Fibrillation 08/2017 - 02/2014
2	Cardiomyopathies (Cardiomyopathy) 08/2014 - 11/2007
2	Polymorphic catecholergic ventricular tachycardia 06/2014 - 03/2014
2	Heart Arrest (Cardiac Arrest) 03/2013 - 07/2004
2	Myocardial Infarction 07/2012 - 04/2011
2	Myotonic Disorders (Paramyotonia Congenita) 03/2011 - 01/2004
2	Myotonia 03/2011 - 01/2004
2	Migraine with Aura (Familial Hemiplegic Migraine) 11/2010 - 07/2008
2	Deafness (Deaf Mutism) 12/2007 - 10/2007
2	Paralysis (Palsy) 04/2006 - 09/2002
2	Generalized Epilepsy 07/2004 - 12/2003
2	Febrile Seizures (Febrile Seizure) 07/2004 - 12/2003
1	Developmental Disabilities (Developmental Disability) 01/2022
1	Autism Spectrum Disorder 01/2021
1	Spasm (Spasms) 01/2021
1	Long Qt Syndrome 3 11/2020
1	Heart Diseases (Heart Disease) 11/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Dyskinesias (Dyskinesia) 01/2020
1	Drug Hypersensitivity Syndrome 01/2018
1	Exanthema (Rash) 01/2018
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

29	Sodium Channels (Sodium Channel)IBA 05/2022 - 10/2003
21	Voltage-Gated Sodium ChannelsIBA 01/2020 - 01/2002
14	Pharmaceutical PreparationsIBA 01/2020 - 03/2002
13	SodiumIBA 01/2021 - 01/2004
12	Ion Channels (Ion Channel)IBA 01/2022 - 08/2005
10	Calmodulin (Calcium-Dependent Activator Protein)IBA 12/2020 - 03/2013
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2005
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022 - 10/2007
4	Anti-Arrhythmia AgentsIBA 11/2020 - 01/2004
4	6- (4- (trifluoromethoxy)phenyl)- 3- (trifluoromethyl)(1,2,4)triazolo(4,3- a)pyridineIBA 01/2018 - 08/2014
4	Chloride Channels (Chloride Channel)IBA 10/2013 - 03/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2017
3	Sodium Channel BlockersIBA 01/2020 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2002
3	PotassiumIBA 01/2016 - 09/2002
3	Ranolazine FDA Link 01/2014 - 11/2010
3	Propranolol (Inderal)FDA LinkGeneric 03/2012 - 12/2008
3	Potassium Channels (Potassium Channel)IBA 02/2012 - 03/2008
2	Mexiletine (Mexitil)FDA LinkGeneric 11/2020 - 01/2004
2	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2002
2	KCNQ1 Potassium ChannelIBA 01/2019 - 10/2017
2	RNA (Ribonucleic Acid)IBA 01/2017 - 02/2014
2	ChloridesIBA 01/2016 - 01/2008
2	NucleotidesIBA 10/2014 - 01/2007
2	Ether (Diethyl Ether)IBA 11/2012 - 08/2004
2	beta Adrenergic ReceptorsIBA 03/2012 - 03/2002
2	SaltsIBA 11/2007 - 03/2005
1	ezogabine (retigabine)IBA 01/2022
1	NAV1.2 Voltage-Gated Sodium ChannelIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Biological ProductsIBA 11/2021
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	4- amino- 8- (2- fluoro- 6- methoxy- phenyl)- N- propylcinnoline- 3- carboxamideIBA 01/2019
1	Explosive Agents (Explosives)IBA 11/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	HLA-A31 antigenIBA 01/2018
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2018
1	CatecholaminesIBA 01/2018
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017

Therapy/Procedure

10	Therapeutics 10/2022 - 07/2004
2	Precision Medicine 10/2022 - 11/2018
2	Drug Therapy (Chemotherapy) 04/2011 - 01/2002
1	Length of Stay 01/2022
1	Induced Hyperthermia (Thermotherapy) 01/2019